Sage Therapeutics (SAGE) SEC Filings & 10K Form

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free sage Stock Alerts

$13.33

+0.29 (+2.22%)

(As of 04/19/2024 ET)

Compare

Recent Sage Therapeutics SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/19/2024 7:31 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/17/2024 5:35 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/26/2024 7:34 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/14/2024 6:49 AM	Sage Therapeutics (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
02/14/2024 6:20 AM	Sage Therapeutics (Filer)	Form 10-K Annual report pursuant to Section 13 or 15(d)
02/14/2024 6:09 AM	RTW INVESTMENTS, LP (Filed by) Sage Therapeutics (Subject)	Form SC 13G
02/14/2024 5:45 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
Get the Latest News and Ratings for SAGE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
02/13/2024 4:13 PM	Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)	Form SC 13G/A
02/13/2024 5:28 AM	Sage Therapeutics (Subject)	Form SC 13G/A
02/13/2024 5:28 AM	BB BIOTECH AG (Filed by) BB BIOTECH AG (Filed by) Sage Therapeutics (Subject)	Form SC 13G/A
02/09/2024 8:49 AM	FMR LLC (Filed by) Sage Therapeutics (Subject)	Form SC 13G/A
02/08/2024 9:17 AM	Sage Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)	Form SC 13G/A
01/31/2024 4:25 PM	Sage Therapeutics (Subject)	Form SC TO-I/A
01/31/2024 3:50 PM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/24/2024 9:04 AM	Sage Therapeutics (Subject) STATE STREET CORP (Filed by)	Form SC 13G
01/23/2024 7:13 AM	Sage Therapeutics (Subject)	Form SC TO-I
01/08/2024 5:45 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/04/2024 3:07 PM	IGUCHI KIMI (Reporting) Sage Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
01/04/2024 3:07 PM	Golumbeski George (Reporting) Sage Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
01/04/2024 3:07 PM	FRATES JAMES M (Reporting) Sage Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
01/04/2024 3:07 PM	PAUL STEVEN M (Reporting) Sage Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
01/04/2024 3:07 PM	Federer Jessica (Reporting) Sage Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
12/19/2023 7:30 AM	Sage Therapeutics (Filer)	Form DEF 14A
12/19/2023 7:32 AM	Sage Therapeutics (Filer)	Form DEFA14A
12/08/2023 8:00 AM	Sage Therapeutics (Subject)	Form SC TO-C
12/08/2023 7:30 AM	Sage Therapeutics (Filer)	Form PRE 14A
12/08/2023 7:30 AM	Sage Therapeutics (Filer)	Form PRE 14A
11/07/2023 6:39 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/07/2023 6:29 AM	Sage Therapeutics (Filer)	Form 424B5
11/07/2023 6:00 AM	Sage Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
11/07/2023 5:46 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/31/2023 5:45 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/11/2023 7:51 AM	Barrett Elizabeth (Reporting) Sage Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
08/07/2023 6:49 AM	Sage Therapeutics (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
08/07/2023 6:20 AM	Sage Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
08/07/2023 5:45 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/10/2023 7:44 AM	Sage Therapeutics (Subject)	Form SC 13G/A
07/10/2023 7:44 AM	Sage Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by) WELLINGTON MANAGEMENT GROUP LLP (Filed by)	Form SC 13G/A
05/11/2023 7:58 AM	Barrett Elizabeth (Reporting) Sage Therapeutics (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
05/02/2023 6:21 AM	Sage Therapeutics (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
05/02/2023 5:45 AM	Sage Therapeutics (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
Biden’s $374B Giveaway Into This Sector (Ad) Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NASDAQ:SAGE) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sage Therapeutics (SAGE) SEC Filings & 10K Form

Recent Sage Therapeutics SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info